359
Views
6
CrossRef citations to date
0
Altmetric
Articles

Guanacastane-type diterpenoids from the insect-associated fungus Verticillium dahliae

, , &
Pages 117-124 | Received 10 Apr 2015, Accepted 08 Jun 2015, Published online: 29 Jul 2015
 

Abstract

Four new guanacastane-type diterpenoids, namely dahlianes A (1), B (2), C (3), and D (4), were isolated from cultures of Verticillium dahliae. Their structures were elucidated on the basis of extensive spectroscopic data analysis. Their absolute configurations were determined by a combination of Mo2(OAc)4-induced electronic circular dichroism experiment and Mosher ester method. In cytotoxicity evaluation against human tumor cell lines, compounds 2 and 3 exhibited significant cytotoxicities against MCF-7 cell lines with IC50 values of 3.35 and 4.72 μM, respectively.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was funded by the Fundamental Research Funds for the Central Universities [JKQZ2013016], the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Youth Fund Project of Basic Research Program of Jiangsu Province (Natural Science Foundation, [BK20130651]), the Program for Changjiang Scholars and Innovative Research Team in University [IRT1193], and the National Natural Science Foundation of China [81073009].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.